Michelle Sexton • UCSD Profiles (original) (raw)

  1. Medical cannabis authorization and opioid milligram equivalents over time in patients with chronic pain: a retrospective analysis. Pain Med. 2026 Feb 01; 27(2):127-135. Sexton M, Glodosky NC, Cleveland M, Cuttler C, Lee E, Polston GR, Furnish T, Lerman I, Schuster NM, Wallace MS. PMID: 40838875; PMCID: PMC12865101.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  2. Vaporized cannabis versus placebo for acute migraine: A randomized, double-blind, placebo-controlled crossover trial. Headache. 2026 Feb; 66(2):365-376. Schuster NM, Wallace MS, Marcotte TD, Buse DC, Lee E, Liu L, Sexton M. PMID: 41469488; PMCID: PMC12872409.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  3. Biphasic effects of cannabis and cannabinoid therapy on pain severity, anxiety, and sleep disturbance: a scoping review. Pain Med. 2024 May 03; 25(6):387-399. Shustorovich A, Corroon J, Wallace MS, Sexton M. PMID: 38268491.
    View in: PubMed Mentions: 9 Fields:
    Translation:HumansAnimals
  4. Vaporized Cannabis versus Placebo for Acute Migraine: A Randomized Controlled Trial. medRxiv. 2024 Feb 18. Schuster NM, Wallace MS, Marcotte TD, Buse DC, Lee E, Liu L, Sexton M. PMID: 38405890; PMCID: PMC10889030.
    View in: PubMed Mentions:
  5. Cannabis use for Sleep Disturbance Among Older Patients in a Geriatrics Clinic. Int J Aging Hum Dev. 2023 07; 97(1):3-17. Kaufmann CN, Malhotra A, Yang KH, Han BH, Nafsu R, Lifset ET, Nguyen K, Sexton M, Moore AA. PMID: 36226368; PMCID: PMC10097827.
    View in: PubMed Mentions: 4 Fields:
    Translation:HumansAnimals
  6. The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids. J Natl Cancer Inst Monogr. 2021 11 28; 2021(58):86-98. Sexton M, Garcia JM, Jatoi A, Clark CS, Wallace MS. PMID: 34850897; PMCID: PMC8848503.
    View in: PubMed Mentions: 16 Fields:
    Translation:Humans
  7. Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms. Cannabis Cannabinoid Res. 2022 10; 7(5):706-716. Russo EB, Cuttler C, Cooper ZD, Stueber A, Whiteley VL, Sexton M. PMID: 34569849; PMCID: PMC9587780.
    View in: PubMed Mentions: 22 Fields:
    Translation:HumansAnimals
  8. Medical Cannabis for Migraine & Pain . Practical Neurology . 2021. Sexton, M and Schuster, N. View Publication.
  9. Cannabidiol as a Treatment for Chronic Pain: A Survey of Patients' Perspectives and Attitudes. J Pain Res. 2021; 14:1241-1250. Schilling JM, Hughes CG, Wallace MS, Sexton M, Backonja M, Moeller-Bertram T. PMID: 33981161; PMCID: PMC8107012.
    View in: PubMed Mentions: 17
  10. The Management of Cancer Symptoms and Treatment-Induced Side Effects with Cannabis of Cannabinoids. Journal of the National Cancer Institute. 2021. Sexton, M; Garcia, JM; Jatoi, A; Clark, CS; Wallace MS .
  11. Cannabis: An Emerging Treatment for Common Symptoms in Older Adults. J Am Geriatr Soc. 2021 01; 69(1):91-97. Yang KH, Kaufmann CN, Nafsu R, Lifset ET, Nguyen K, Sexton M, Han BH, Kim A, Moore AA. PMID: 33026117; PMCID: PMC8962510.
    View in: PubMed Mentions: 45 Fields:
    Translation:HumansAnimals
  12. Medical Cannabis: A New Old Tool for Palliative Care. J Altern Complement Med. 2020 Sep; 26(9):776-778. Kogan M, Sexton M. PMID: 32924552.
    View in: PubMed Mentions: Fields:
    Translation:HumansAnimals
  13. Cannabis in the Time of Coronavirus Disease 2019: The Yin and Yang of the Endocannabinoid System in Immunocompetence. J Altern Complement Med. 2020 Jun; 26(6):444-448. Sexton M. PMID: 32380847.
    View in: PubMed Mentions: 13 Fields:
    Translation:HumansCellsPHPublic Health
  14. Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey. BMC Fam Pract. 2019 12 14; 20(1):174. Corroon J, Sexton M, Bradley R. PMID: 31837706; PMCID: PMC6911295.
    View in: PubMed Mentions: 14 Fields:
    Translation:Humans
  15. Allostatic load and the cannabinoid system: implications for the treatment of physiological abnormalities in post-traumatic stress disorder (PTSD). CNS Spectr. 2020 12; 25(6):743-749. Lohr JB, Chang H, Sexton M, Palmer BW. PMID: 31303187; PMCID: PMC6960358.
    View in: PubMed Mentions: 6 Fields:
    Translation:HumansAnimals
  16. A Survey of Cannabis Acute Effects and Withdrawal Symptoms: Differential Responses Across User Types and Age. J Altern Complement Med. 2019 Mar; 25(3):326-335. Sexton M, Cuttler C, Mischley LK. PMID: 30383388; PMCID: PMC6437627.
    View in: PubMed Mentions: 31 Fields:
    Translation:HumansAnimals
  17. Driving Under the Influence of Cannabis: An Examination of Driving Beliefs and Practices of Medical and Recreational Cannabis Users Across the United States. Cannabis. 2018; 2(1):1-13. Cuttler, C; Sexton, M; Mischley, LK.
  18. Erratum: Evaluation of Cannabinoid and Terpenoid Content: Cannabis Flower Compared to Supercritical CO2 Concentrate. Planta Med. 2018 03; 84(4):E3. Sexton M, Shelton K, Haley P, West M. PMID: 29165726.
    View in: PubMed Mentions: Fields:
  19. Evaluation of Cannabinoid and Terpenoid Content: Cannabis Flower Compared to Supercritical CO2 Concentrate. Planta Med. 2018 Mar; 84(4):234-241. Sexton M, Shelton K, Haley P, West M. PMID: 28926863.
    View in: PubMed Mentions: 26 Fields:
    Translation:Animals
  20. Cannabis as a substitute for prescription drugs - a cross-sectional study. J Pain Res. 2017; 10:989-998. Corroon JM, Mischley LK, Sexton M. PMID: 28496355; PMCID: PMC5422566.
    View in: PubMed Mentions: 105
  21. Sex Differences in Cannabis Use and Effects: A Cross-Sectional Survey of Cannabis Users. Cannabis Cannabinoid Res. 2016; 1(1):166-175. Cuttler C, Mischley LK, Sexton M. PMID: 28861492; PMCID: PMC5576608.
    View in: PubMed Mentions: 162 Fields:
  22. A Cross-Sectional Survey of Medical Cannabis Users: Patterns of Use and Perceived Efficacy. Cannabis Cannabinoid Res. 2016; 1(1):131-138. Sexton M, Cuttler C, Finnell JS, Mischley LK. PMID: 28861489; PMCID: PMC5549439.
    View in: PubMed Mentions: 139 Fields:
  23. Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters. Inflammopharmacology. 2014 Oct; 22(5):295-303. Sexton M, Cudaback E, Abdullah RA, Finnell J, Mischley LK, Rozga M, Lichtman AH, Stella N. PMID: 25135301; PMCID: PMC4170074.
    View in: PubMed Mentions: 10 Fields:
    Translation:HumansAnimalsCells
  24. Differential migratory properties of monocytes isolated from human subjects naïve and non-naïve to Cannabis. Inflammopharmacology. 2013 Jun; 21(3):253-9. Sexton M, Silvestroni A, Möller T, Stella N. PMID: 22492174; PMCID: PMC4476512.
    View in: PubMed Mentions: 9 Fields:
    Translation:HumansAnimalsCells
  25. NIR-mbc94, a fluorescent ligand that binds to endogenous CB(2) receptors and is amenable to high-throughput screening. Chem Biol. 2011 May 27; 18(5):563-8. Sexton M, Woodruff G, Horne EA, Lin YH, Muccioli GG, Bai M, Stern E, Bornhop DJ, Stella N. PMID: 21609837; PMCID: PMC3420821.
    View in: PubMed Mentions: 16 Fields:
    Translation:AnimalsCells
  26. Binding of NIR-conPK and NIR-6T to astrocytomas and microglial cells: evidence for a protein related to TSPO. PLoS One. 2009 Dec 18; 4(12):e8271. Sexton M, Woodruff G, Cudaback E, Kreitzer FR, Xu C, Lin YH, Möller T, Bai M, Manning HC, Bornhop D, Stella N. PMID: 20020060; PMCID: PMC2792720.
    View in: PubMed Mentions: 5 Fields:
    Translation:AnimalsCells
  27. MBC94, a conjugable ligand for cannabinoid CB 2 receptor imaging. Bioconjug Chem. 2008 May; 19(5):988-92. Bai M, Sexton M, Stella N, Bornhop DJ. PMID: 18444670; PMCID: PMC4180707.
    View in: PubMed Mentions: 16 Fields:
    Translation:AnimalsCells
  28. A peripheral benzodiazepine receptor targeted agent for in vitro imaging and screening. Bioconjug Chem. 2006 May-Jun; 17(3):735-40. Manning HC, Smith SM, Sexton M, Haviland S, Bai M, Cederquist K, Stella N, Bornhop DJ. PMID: 16704212.
    View in: PubMed Mentions: 12 Fields:
    Translation:HumansAnimalsCells

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

Start with: newest oldestInclude: line numbers double spacing all authors publication IDs